Tandem Diabetes Care (TNDM) Tax Rate Growth (3y) (2021 - 2026)
Tandem Diabetes Care (TNDM) Tax Rate Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Tandem Diabetes Care | 1.14 Bn | 574.71 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -227.00 |
| Dec 31, 2025 | 10,987.00 |
| Sep 30, 2025 | 1,920.00 |
| Jun 30, 2025 | 2,540.00 |
| Mar 31, 2025 | -1,730.00 |
| Dec 31, 2024 | -462,179.00 |
| Sep 30, 2024 | -358.00 |
| Jun 30, 2024 | -604.00 |
| Mar 31, 2024 | -1,002.00 |
| Sep 30, 2023 | -685.00 |
| Jun 30, 2023 | -327.00 |
| Mar 31, 2023 | 42.00 |
| Dec 31, 2022 | -121.00 |
| Sep 30, 2022 | -83.00 |
| Dec 31, 2021 | 167.00 |